Protocol and establishment of a Queensland renal biopsy registry in Australia
Burke, Joseph Patrick, Aljishi, Manaf, Francis, Leo, Hoy, Wendy, Divi, Dakshinamurthy, Cherian, Roy, Frazier, Jeremy, Gobe, Glenda, Gois, Pedro, Govindarajulu, Sridevi, Huynh, Sonny, Jesudason, Shilpanjali, John, George, Madhan, Krishan, Mallett, Andrew, Manickam, Valli, Mutatiri, Clyson, Ng, Shu-Kay, Thet, Zaw, Trnka, Peter, Venuthurupalli, Sree Krishna, and Ranganathan, Dwarakanathan (2020) Protocol and establishment of a Queensland renal biopsy registry in Australia. BMC Nephrology, 21. 320.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (668kB) | Preview |
Abstract
Background: Renal biopsy is often required to obtain information for diagnosis, management and prognosis of kidney disease that can be broadly classified into acute kidney injury (AKI) and chronic kidney disease (CKD). The most common conditions identified on renal biopsy are glomerulonephritis and tubulo-interstitial disorders. There is a paucity of information on management strategies and therapeutic outcomes in AKI and CKD patients. A renal biopsy registry will provide information on biopsy-proven kidney disorders to improve disease understanding and tracking, healthcare planning, patient care and outcomes.
Methods: A registry of patients, that includes biopsy-proven kidney disease, was established through the collaboration of nephrologists from Queensland Hospital and Health Services and pathologists from Pathology Queensland services. The registry is in keeping with directions of the Advancing Kidney Care 2026 Collaborative, established in September 2018 as a Queensland Health initiative. Phase 1 of the registry entailed retrospective acquisition of data from all adult native kidney biopsies performed in Queensland, Australia, from 2002 to 2018. Data were also linked with the existing CKD.QLD patient registry. From 2019 onwards, phase 2 of the registry involves prospective collection of all incident consenting patients referred to Queensland public hospitals and having a renal biopsy. Annual reports on patient outcomes will be generated and disseminated.
Discussion: Establishment of the Queensland Renal Biopsy Registry (QRBR) aims to provide a profile of patients with biopsy-proven kidney disease that will lead to better understanding of clinico-pathological association and facilitate future research. It is expected to improve patient care and outcomes.
Item ID: | 67864 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1471-2369 |
Copyright Information: | © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
Date Deposited: | 05 Jul 2022 06:39 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320214 Nephrology and urology @ 100% |
SEO Codes: | 20 HEALTH > 2001 Clinical health > 200105 Treatment of human diseases and conditions @ 100% |
Downloads: |
Total: 617 Last 12 Months: 12 |
More Statistics |